Money Matters
Filed under Startup financing, Venture capital, Life scienceWith JP Morgan fast approaching, as well as the Biotech Showcase and Medtech Showcases and RESI, all in the same few days of January, we have… Read more
With JP Morgan fast approaching, as well as the Biotech Showcase and Medtech Showcases and RESI, all in the same few days of January, we have… Read more
I recently spoke with several corporate venture capital investors (CVCs) when I moderated a panel at the 2014 RESI Conference. The discussion gave definition about… Read more
On November 20th I hosted a panel of experts representing medical devices, diagnostics, research tools, and biopharma at Minnesota’s LifeScience Alley’s 2013 annual conference. The… Read more
We’re well into the era when dwindling venture capital is no longer the first or best option for raising money to seed a new company… Read more
Successful fundraising campaigns target investors whose interests match the firm’s product offerings and stage of development. If you have an early-stage life science company looking… Read more